Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ: BOLT · Real-Time Price · USD
0.3230
+0.0250 (8.39%)
At close: Jun 6, 2025, 4:00 PM
0.3106
-0.0124 (-3.84%)
After-hours: Jun 6, 2025, 7:30 PM EDT
Bolt Biotherapeutics Stock Forecast
BOLT's stock price has decreased by -57.1% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 2 professional analysts, the 12-month price target for Bolt Biotherapeutics stock ranges from a low of $1.00 to a high of $4.00. The average analyst price target of $2.50 forecasts a 673.99% increase in the stock price over the next year.
Price Target: $2.50 (+673.99%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Bolt Biotherapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 5 | 5 | 5 | 5 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Lake Street | Lake Street | Strong Buy Initiates $4 | Strong Buy | Initiates | $4 | +1,138.39% | May 20, 2025 |
| Stifel | Stifel | Hold Maintains $1.25 → $1 | Hold | Maintains | $1.25 → $1 | +209.60% | May 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Mar 25, 2025 |
| Stifel | Stifel | Hold Maintains $1.5 → $1.25 | Hold | Maintains | $1.5 → $1.25 | +287.00% | Mar 25, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Nov 13, 2024 |
Financial Forecast
Revenue This Year
2.73M
from 7.69M
Decreased by -64.45%
Revenue Next Year
5.39M
from 2.73M
Increased by 97.29%
EPS This Year
-1.39
from -1.65
EPS Next Year
-0.99
from -1.39
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 5.3M | 15.9M | 38.4M | ||
| Avg | 2.7M | 5.4M | 18.8M | ||
| Low | n/a | n/a | 294,000 |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -31.2% | 482.4% | 612.1% | ||
| Avg | -64.4% | 97.3% | 248.7% | ||
| Low | - | - | -94.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.07 | -0.59 | -0.36 | ||
| Avg | -1.39 | -0.99 | -0.38 | ||
| Low | -1.81 | -1.89 | -0.41 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.